FRBRX - Franklin Biotechnology Discovery R6

Nasdaq - Nasdaq Delayed Price. Currency in USD
160.35
+1.60 (+1.01%)
At close: 8:00PM EST
Stock chart is not supported by your current browser
Previous Close158.75
YTD Return19.32%
Expense Ratio (net)0.61%
CategoryHealth
Morningstar Rating★☆☆☆☆
Morningstar Risk RatingAbove Average
Last Cap Gain0.00
Net Assets1.37B
Beta (3y)1.33
Yield0.00%
Holdings Turnover34.12%
Last Dividend1.33
Inception DateMay 1, 2013
Average for CategoryN/A
  • We're sorry we weren't able to find anything about this topic.